안정 동위체 표지 화합물 시장 : 시장 규모 - 유형별, 용도별, 최종 사용자별, 지역별 분석 및 예측(2022-2032년)

The Global Stable Isotope Labeled Compounds Market, valued at approximately USD 302.76 million in 2023, is projected to grow at a modest compound annual growth rate (CAGR) of 3.00% from 2024 to 2032, culminating in a market value of USD 395.03 million by the end of the forecast period. Stable isotope labeled compounds are integral to a myriad of scientific applications, spanning pharmaceutical research, clinical diagnostics, and industrial processes. These compounds, marked by their non-radioactive and stable isotope signatures, enable precise measurement and analysis in chemical, biological, and environmental studies.

The market's growth is driven by escalating demand in pharmaceutical and biopharmaceutical research. Stable isotope labeled compounds are indispensable in drug development processes, facilitating pharmacokinetic and pharmacodynamic studies. Their role in enhancing the accuracy of mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy has solidified their importance in clinical diagnostics and quality control applications. Furthermore, industrial use cases, including tracing and environmental analysis, have expanded the market's scope, signaling robust and sustained demand across various verticals.

However, the market faces challenges, including high production costs and the technical complexities associated with the synthesis of these compounds. Limited accessibility in resource-constrained settings and the expertise required to effectively employ these compounds also pose barriers to widespread adoption. Nonetheless, advances in isotope enrichment technologies, coupled with increased collaboration between academic institutes and industry players, are expected to mitigate these challenges. Emerging economies, with their growing focus on research and diagnostics, offer lucrative opportunities for market expansion.

Regionally, North America dominates the stable isotope labeled compounds market, driven by a well-established pharmaceutical industry, significant investments in R&D, and the presence of leading market players. Europe follows closely, benefiting from a robust academic research ecosystem and supportive government funding. Meanwhile, the Asia-Pacific region is anticipated to exhibit the fastest growth, spurred by rising pharmaceutical production, increased healthcare expenditure, and growing investments in scientific research across countries like China, India, and Japan.

Major market players included in this report are:

• Cambridge Isotope Laboratories, Inc.
• Merck KGaA
• IsoSciences, LLC
• Omicron Biochemicals, Inc.
• Trace Sciences International
• Urenco Limited
• CortecNet
• Medical Isotopes, Inc.
• Rotem Industries Ltd.
• Alsachim SAS
• Taiyo Nippon Sanso Corporation
• PerkinElmer, Inc.
• Sigma-Aldrich Corporation
• JSC Isotope
• LGC Limited

The detailed segments and sub-segment of the market are explained below:

By Type:

• Carbon 13
• Deuterium (D)
• Oxygen 18
• Nitrogen 15

By Application:

• Research
• Clinical Diagnostics
• Industrial

By End User:

• Pharmaceutical & Biopharmaceutical Companies
• Academic Institutes

By Region:

North America:

• U.S.
• Canada

Europe:

• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific:

• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America:

• Brazil
• Mexico

Middle East & Africa:

• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of the geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approaches.
• Analysis of competitive structure of the market.
• Demand-side and supply-side analysis of the market.

Table of Contents

Chapter 1. Global Stable Isotope Labeled Compounds Market Executive Summary

• 1.1. Global Stable Isotope Labeled Compounds Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Type
  • 1.3.2. By Application
  • 1.3.3. By End User
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Stable Isotope Labeled Compounds Market Definition and Research Assumptions

]
• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory Frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Stable Isotope Labeled Compounds Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Rising Demand in Pharmaceutical and Biopharmaceutical Research
  • 3.1.2. Advancements in Analytical Technologies
  • 3.1.3. Increasing Applications in Clinical Diagnostics and Industrial Processes
• 3.2. Market Challenges
  • 3.2.1. High Production Costs
  • 3.2.2. Technical Complexities in Synthesis
• 3.3. Market Opportunities
  • 3.3.1. Innovations in Isotope Enrichment Technologies
  • 3.3.2. Strategic Collaborations Between Academia and Industry
  • 3.3.3. Expansion in Emerging Economies

Chapter 4. Global Stable Isotope Labeled Compounds Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top Investment Opportunity
• 4.4. Top Winning Strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Stable Isotope Labeled Compounds Market Size & Forecasts by Type 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Stable Isotope Labeled Compounds Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
  • 5.2.1. Carbon 13
  • 5.2.2. Deuterium (D)
  • 5.2.3. Oxygen 18
  • 5.2.4. Nitrogen 15
  • 5.2.5. Others

Chapter 6. Global Stable Isotope Labeled Compounds Market Size & Forecasts by Application 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global Stable Isotope Labeled Compounds Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
  • 6.2.1. Research
  • 6.2.2. Clinical Diagnostics
  • 6.2.3. Industrial

Chapter 7. Global Stable Isotope Labeled Compounds Market Size & Forecasts by End User 2022-2032

• 7.1. Segment Dashboard
• 7.2. Global Stable Isotope Labeled Compounds Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
  • 7.2.1. Pharmaceutical & Biopharmaceutical Companies
  • 7.2.2. Academic Institutes
  • 7.2.3. Others

Chapter 8. Global Stable Isotope Labeled Compounds Market Size & Forecasts by Region 2022-2032

• 8.1. North America Stable Isotope Labeled Compounds Market
  • 8.1.1. U.S. Stable Isotope Labeled Compounds Market
    • 8.1.1.1. Type Breakdown Size & Forecasts, 2022-2032
    • 8.1.1.2. Application Breakdown Size & Forecasts, 2022-2032
    • 8.1.1.3. End User Breakdown Size & Forecasts, 2022-2032
    • 8.1.1.4. Others Breakdown Size & Forecasts, 2022-2032
  • 8.1.2. Canada Stable Isotope Labeled Compounds Market
• 8.2. Europe Stable Isotope Labeled Compounds Market
  • 8.2.1. UK Stable Isotope Labeled Compounds Market
  • 8.2.2. Germany Stable Isotope Labeled Compounds Market
  • 8.2.3. France Stable Isotope Labeled Compounds Market
  • 8.2.4. Spain Stable Isotope Labeled Compounds Market
  • 8.2.5. Italy Stable Isotope Labeled Compounds Market
  • 8.2.6. Rest of Europe Stable Isotope Labeled Compounds Market
• 8.3. Asia-Pacific Stable Isotope Labeled Compounds Market
  • 8.3.1. China Stable Isotope Labeled Compounds Market
  • 8.3.2. India Stable Isotope Labeled Compounds Market
  • 8.3.3. Japan Stable Isotope Labeled Compounds Market
  • 8.3.4. Australia Stable Isotope Labeled Compounds Market
  • 8.3.5. South Korea Stable Isotope Labeled Compounds Market
  • 8.3.6. Rest of Asia Pacific Stable Isotope Labeled Compounds Market
• 8.4. Latin America Stable Isotope Labeled Compounds Market
  • 8.4.1. Brazil Stable Isotope Labeled Compounds Market
  • 8.4.2. Mexico Stable Isotope Labeled Compounds Market
  • 8.4.3. Rest of Latin America Stable Isotope Labeled Compounds Market
• 8.5. Middle East & Africa Stable Isotope Labeled Compounds Market
  • 8.5.1. Saudi Arabia Stable Isotope Labeled Compounds Market
  • 8.5.2. South Africa Stable Isotope Labeled Compounds Market
  • 8.5.3. Rest of Middle East & Africa Stable Isotope Labeled Compounds Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
  • 9.1.1. Cambridge Isotope Laboratories, Inc.
  • 9.1.2. Merck KGaA
  • 9.1.3. IsoSciences, LLC
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. Cambridge Isotope Laboratories, Inc.
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Market Strategies
  • 9.3.2. Merck KGaA
  • 9.3.3. IsoSciences, LLC
  • 9.3.4. Omicron Biochemicals, Inc.
  • 9.3.5. Trace Sciences International
  • 9.3.6. Urenco Limited
  • 9.3.7. CortecNet
  • 9.3.8. Medical Isotopes, Inc.
  • 9.3.9. Rotem Industries Ltd.
  • 9.3.10. Alsachim SAS
  • 9.3.11. Taiyo Nippon Sanso Corporation
  • 9.3.12. PerkinElmer, Inc.
  • 9.3.13. Sigma-Aldrich Corporation
  • 9.3.14. JSC Isotope
  • 9.3.15. LGC Limited

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes